Search by Drug Name or NDC
NDC 44206-0456-21 Hizentra 0.2 g/mL Details
Hizentra 0.2 g/mL
Hizentra is a SUBCUTANEOUS LIQUID in the PLASMA DERIVATIVE category. It is labeled and distributed by CSL Behring AG. The primary component is HUMAN IMMUNOGLOBULIN G.
Product Information
| NDC | 44206-0456 |
|---|---|
| Product ID | 44206-456_411c01a7-0ae7-45d2-8b4c-cbe99a2ba264 |
| Associated GPIs | 1910002020E520 |
| GCN Sequence Number | 078373 |
| GCN Sequence Number Description | immun glob G(IgG)/pro/IgA 0-50 SYRINGE 1 G/5 ML SUBCUT |
| HIC3 | W7K |
| HIC3 Description | ANTISERA |
| GCN | 44679 |
| HICL Sequence Number | 041798 |
| HICL Sequence Number Description | IMMUNE GLOBULIN,GAMMA (IGG)/PROLINE/IGA 0 TO 50 MCG/ML |
| Brand/Generic | Brand |
| Proprietary Name | Hizentra |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | HUMAN IMMUNOGLOBULIN G |
| Product Type | PLASMA DERIVATIVE |
| Dosage Form | LIQUID |
| Route | SUBCUTANEOUS |
| Active Ingredient Strength | 0.2 |
| Active Ingredient Units | g/mL |
| Substance Name | HUMAN IMMUNOGLOBULIN G |
| Labeler Name | CSL Behring AG |
| Pharmaceutical Class | Antigen Neutralization [MoA], Human Immunoglobulin G [EPC], Immunoglobulins [CS], Passively Acquired Immunity [PE] |
| DEA Schedule | n/a |
| Marketing Category | BLA |
| Application Number | BLA125350 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 44206-0456-21 (44206045621)
| NDC Package Code | 44206-456-21 |
|---|---|
| Billing NDC | 44206045621 |
| Package | 1 SYRINGE in 1 CARTON (44206-456-21) / 5 mL in 1 SYRINGE (44206-456-94) |
| Marketing Start Date | 2020-01-01 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |